作者：
Nathan B,Buila [1]
;
Georges N,Ngoyi [1]
;
Pascal M,Bayauli [2]
;
Fortunat K,Katamba [1]
;
Yves N,Lubenga [1]
;
Serge M,Kazadi [1]
;
Glodie D,Kiadi [1]
;
François B,Lepira [3]
;
Gilbert K,Kabanda [1]
;
Mireille L,Kika [4]
;
Thomas,Beaney [5]
;
Anca Chis,Ster [6]
;
Neil R,Poulter [5]
;
Jean-René,M'Buyamba-Kabangu [5]
;
MMM18/DRC investigators [1]
作者单位：
Hypertension Unit, Division of Cardiology, Department of Internal Medicine, University of Kinshasa Hospital, University of Kinshasa, Kinshasa 11, Democratic Republic of the Congo.
[1]
Division of Endocrinology and Nuclear Medicine, University of Kinshasa Hospital, Kinshasa 11, Democratic Republic of the Congo.
[2]
Division of Nephrology, Kinshasa School of Medicine, University of Kinshasa, Kinshasa 11, Democratic Republic of the Congo.
[3]
Programme National de Lutte contre les Maladies Cardiovasculaires, Ministère de la Santé Publique, Kinshasa Gombe, Democratic Republic of the Congo.
[4]
Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
[5]
Department of Primary Care and Public Health, Imperial College London, St Dunstan's Road, London W6 8RP, UK.
[6]
DOI
10.1093/eurheartj/suaa027
PMID
32884469
发布时间
2020-09-05
换一批
换一批
